Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Anastomotic failure (AF), including anastomotic leakage (AL), increases morbidity and mortality after colorectal cancer (CRC) resection. An inadequate perfusion of the anastomosis or technical stapling defects may contribute to AF. Several studies evaluated the singular use of intraoperative near infrared (NIR) indocyanine green (ICG)-induced fluorescence angiography (FA) and air leak testing to assess the integrity and the perfusion levels of the colorectal anastomosis. So far, a combined use of these methodologies, although acknowledged has not yet been tested as an indicator of postoperative AF or of intra-operative anastomotic repair in a prospective setting. This study aims to implement the intraoperative anastomotic assessment in a prospective series of patients undergoing rectal resection plus primary anastomosis for rectal cancer with or without ostomy, using a semi-quantitative check of 4 items (4-check). The procedure will include NIR-ICG-induced FA (to assess perfusion), air leak test and evaluation of the anastomotic donuts (to assess for the presence of technical defects). Included patients will be those scheduled for elective rectal resection with total or partial mesorectal excision and primary colo-rectal anastomosis with/or without protective ostomy. Primary outcomes will be the overall incidence of intra-operative anastomotic repair and the rate of post-operative AF. Secondary outcomes will be the overall incidence of adverse events and serious complications, the estimation of costs and resources, the operative time, hospitalization and post-operative measurement of inflammatory markers.
All consecutive patients undergoing rectal resection (open and mini-invasive procedures) plus primary anastomosis for rectal cancer selected for the study will udergo a surgical intra-operative assessment of the anastomosis based on the check of the following 4 items (4-check):
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| REC4T study patients | Rectal adenocarcinoma or polyp with indication for resection and primary colo-rectal mechanical anastomosis using a circular stapler with/or without protective ostomy undergoing upfront surgery and patients undergoing neoadjuvant therapy followed by surgery (see Inclusion/Exclusion Criteria) |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| intraoperative near infrared (NIR) indocyanine green (ICG)-induced fluorescence angiography (FA) and air leak testing to assess the integrity and the perfusion levels of the colorectal anastomosis | Combination Product | Extra-luminal (serosa) and Endo-luminal (mucosal) evaluation of the proximal colon and distal rectal stump perfusion based on a semi-quantitative NIR-ICG-induced FA. This will be conducted administering IV a bolus of 3.75 to 7.5 mg of ICG and evaluated using a Fluorescence Imaging System; following after completion of the anastomosis a second bolos of 3.75 to 7.5 mg of ICG will be administered IV and the anastomosis will be visualized by insertion of the system trans-anally. Colon and rectal segments and quadrants will be scored for any defect of perfusion. |
| Measure | Description | Time Frame |
|---|---|---|
| intra-operative anastomosis repairs | defined as additional suturing or re-do anastomosis | 01/01/2021 to 31/12/2022 |
| Rate of 30 day-anastomotic failure (AF) | defined as anastomotic-related morbidity, including anastomotic leakage, pelvic abscess, anastomotic-related fistula, sinus, and anastomotic stricture | 01/01/2021 to 31/12/2022 |
| Measure | Description | Time Frame |
|---|---|---|
| Rate of of adverse events | any medical or surgical complications | 01/01/2021 to 31/12/2022 |
| Rate of 30-day major complications | Clavien-Dindo grade IIIb-IV |
Not provided
Inclusion Criteria:
Exclusion Criteria:
• Patient pregnant or suspected pregnancy.
Not provided
Not provided
Not provided
Selected patients will receive oral bowel preparation as for colonoscopy, 2 days before surgery and managed with ERAS protocol. Patients should be treated with rectal resection with TME or PME and mechanical anastomosis with a circular stapler, using one of the following approaches:
The following procedures is required during surgery:
Routine splenic flexure mobilization.
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Roberto Persiani, MD | Contact | 0630154511 | 0630154511 | roberto.persiani@policlinicogemelli.it |
| Laura Lorenzon, MD PhD | Contact | laura.lorenzon@policlinicogemelli.it |
| Name | Affiliation | Role |
|---|---|---|
| Roberto Persiani, MD | Fondazione Policlinico Universitarioa A Gemelli IRCCS | Principal Investigator |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
|
|
| Air Leak test | Diagnostic Test | This will be conducted insufflaying air in the anastomosis through a proctoscope, tube or a flexible endoscope, after filling of the pelvis with saline solution and luminal occlusion of the intestine proximal to the anastomosis. Also, the anastomosis will be checked transanally for the presence of air leak. |
|
| Evaluation of the anastomotic rings | Diagnostic Test | The assessment of the anastomotic rings following mechanical anastomosis will be recorded as complete/incomplete |
|
| 01/01/2021 to 31/12/2022 |
| Measure of costs | Costs resource utilization for the procedure | 01/01/2021 to 31/12/2022 |
| Medan length of post-operative stay | post-operative stay (measured in days) | 01/01/2021 to 31/12/2022 |
| C-Reactive Protein (CRP) measurement | measurement conducted in postoperative days 1, 3 & 5 (optional) using mg/L | 01/01/2021 to 31/12/2022 |
| Procalcitonin (PCT) measurement | measurement conducted in postoperative days 1, 3 & 5 (optional) using mg/L ng/mL | 01/01/2021 to 31/12/2022 |
| ID | Term |
|---|---|
| D012004 | Rectal Neoplasms |
| ID | Term |
|---|---|
| D015179 | Colorectal Neoplasms |
| D007414 | Intestinal Neoplasms |
| D005770 | Gastrointestinal Neoplasms |
| D004067 | Digestive System Neoplasms |
| D009371 | Neoplasms by Site |
| D009369 | Neoplasms |
| D004066 | Digestive System Diseases |
| D005767 | Gastrointestinal Diseases |
| D007410 | Intestinal Diseases |
| D012002 | Rectal Diseases |
Not provided
Not provided
| ID | Term |
|---|---|
| D007208 | Indocyanine Green |
| ID | Term |
|---|---|
| D007211 | Indoles |
| D006574 | Heterocyclic Compounds, 2-Ring |
| D000072471 | Heterocyclic Compounds, Fused-Ring |
| D006571 | Heterocyclic Compounds |
Not provided
Not provided